chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a health care professional and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 029L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. The patient's last menstrual period was on 27-Sep-2020 and the estimated date of delivery was 04-Jul-2021. On 20-Jan-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twentieth week of the pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Pregnant) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Oct-2020, Pregnancy test: positive (Positive) Positive. In February 2021, Ultrasound scan: single umbilical artery (Inconclusive) Positive Pregnancy test and Single Umbilical artery.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Complications or acute illnesses during pregnancy includes Single Umbilical artery.  Action taken with mRNA-1273 in response to the event was not applicable.  No Concomitant medication were reported.  No treatment medication were reported.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow Up received on 15-JUN-2021.  Updated Reporter Contact Information.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Dose given more than 6 hours after first vial puncture; This spontaneous case was reported by a health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Dose given more than 6 hours after first vial puncture) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Dose given more than 6 hours after first vial puncture). On 13-Mar-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Dose given more than 6 hours after first vial puncture) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant and Treatment medications were not provided by reporter.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: itching; Rash; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching) and RASH (Rash) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (itching) and RASH (Rash). At the time of the report, PRURITUS (itching) and RASH (Rash) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided. Patient took steroid cream as treatment medication.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Dizziness, Fatigue, Nausea, Vertigo
Clinical narrative: Severe vertigo; Nausea; Had to lay in bed the whole day; Could barely make it to the bathroom/ was going to fall all day; Very dizzy; This spontaneous case was reported by a patient and describes the occurrence of VERTIGO (Severe vertigo), NAUSEA (Nausea), FATIGUE (Had to lay in bed the whole day), BALANCE DISORDER (Could barely make it to the bathroom/ was going to fall all day) and DIZZINESS (Very dizzy) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced VERTIGO (Severe vertigo), NAUSEA (Nausea), FATIGUE (Had to lay in bed the whole day), BALANCE DISORDER (Could barely make it to the bathroom/ was going to fall all day) and DIZZINESS (Very dizzy). At the time of the report, VERTIGO (Severe vertigo), NAUSEA (Nausea), FATIGUE (Had to lay in bed the whole day), BALANCE DISORDER (Could barely make it to the bathroom/ was going to fall all day) and DIZZINESS (Very dizzy) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  No treatment medications were provided.
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: swelling on the inside of her arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (swelling on the inside of her arm) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination.     Concomitant products included CYCLOBENZAPRINE for COVID-19 vaccination, THIAMINE, MONTELUKAST, ATORVASTATIN, HYDROCHLOROTHIAZIDE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), METFORMIN, GABAPENTIN, FOLIC ACID, FLUTICASONE FUROATE, VILANTEROL TRIFENATATE (BREO ELLIPTA), ALBUTEROL [SALBUTAMOL] and SALBUTAMOL SULFATE (VENTOLIN ACCUHALER) for an unknown indication.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced PERIPHERAL SWELLING (swelling on the inside of her arm). At the time of the report, PERIPHERAL SWELLING (swelling on the inside of her arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Off label use
Clinical narrative: Holding off the second vaccine indefinately; This spontaneous case was reported by a pharmacist and describes the occurrence of OFF LABEL USE (Holding off the second vaccine indefinately) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031M20A) for COVID-19 vaccination.     The patient's past medical history included Surgery (Surgery unrelated to vaccine) on 12-Mar-2021.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced OFF LABEL USE (Holding off the second vaccine indefinately). On 16-Mar-2021, OFF LABEL USE (Holding off the second vaccine indefinately) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing was delayed on an unknown date.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided. Treatment information was not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: injection site itchiness; mild rash on injection arm covering 3inx3in area around injection site; This spontaneous case was reported by an other and describes the occurrence of VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE RASH (mild rash on injection arm covering 3inx3in area around injection site) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031M20A and 031L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE RASH (mild rash on injection arm covering 3inx3in area around injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at an unspecified dose and frequency and CROTAMITON (ANTI ITCH CREAM [CROTAMITON]) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PRURITUS (injection site itchiness) and VACCINATION SITE RASH (mild rash on injection arm covering 3inx3in area around injection site) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were given Treatment information was provided as tylenol, iced injection site and used anti-itch cream to help relieve symptoms  Patient reports getting 2nd dose of Moderna Covid-19 Vaccine on 10Mar2021. Patient reports getting vaccination at pharmacy. Patient experienced injection site itchiness, mild rash on injection arm covering 3inx3in area around injection site. Symptoms started a few days after vaccination 12Mar2021 and are ongoing.
Age: 26.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Hypersensitivity, Night sweats, Swelling face
Clinical narrative: Night sweats; Headache; chills; Face blew up; Allergic reaction; This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Allergic reaction), NIGHT SWEATS (Night sweats), SWELLING FACE (Face blew up), HEADACHE (Headache) and CHILLS (chills) in a 26-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 024M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced HYPERSENSITIVITY (Allergic reaction) and SWELLING FACE (Face blew up). On 07-Mar-2021, the patient experienced NIGHT SWEATS (Night sweats), HEADACHE (Headache) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency; PREDNISONE at an unspecified dose and frequency and DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency. On 06-Mar-2021, HYPERSENSITIVITY (Allergic reaction) and SWELLING FACE (Face blew up) had resolved. On 11-Mar-2021, NIGHT SWEATS (Night sweats), HEADACHE (Headache) and CHILLS (chills) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication provided.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong technique in product usage process
Clinical narrative: Patient was administered 1st dose of the vaccine more than 6 hours after first vial puncture; This spontaneous case was reported by a health care professional and describes the occurrence of WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Patient was administered 1st dose of the vaccine more than 6 hours after first vial puncture) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Patient was administered 1st dose of the vaccine more than 6 hours after first vial puncture). On 15-Mar-2021, WRONG TECHNIQUE IN PRODUCT USAGE PROCESS (Patient was administered 1st dose of the vaccine more than 6 hours after first vial puncture) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.; Reporter's Comments: This report refers to a case of wrong technique in product usage process for mRNA-1273, lot # 030A21A with no associated AEs.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Diarrhoea, Nausea
Clinical narrative: After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose; After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose; After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose; This spontaneous case was reported by a health care professional and describes the occurrence of ABDOMINAL DISCOMFORT (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose), DIARRHOEA (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose) and NAUSEA (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 026L20A and 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose), DIARRHOEA (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose) and NAUSEA (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose). The patient was treated with CALCIUM CARBONATE (MYLANTA [CALCIUM CARBONATE]) at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose), DIARRHOEA (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose) and NAUSEA (After the second, now, they are feeling worse nausea, upset stomach and feel their bowels are loose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medication use was blood pressure medication and others, they did not remember at the time  The treatment medication was Mylanta.
Sex: U
Vaccine: COVID19
Symptoms: Device connection issue, Underdose
Clinical narrative: Some of the vaccine (approximately 0.1ml ) leaked out; Needle tip came loss from the syringe; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of UNDERDOSE (Some of the vaccine (approximately 0.1ml ) leaked out) and DEVICE CONNECTION ISSUE (Needle tip came loss from the syringe) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Mar-2021 at 2:33 PM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced UNDERDOSE (Some of the vaccine (approximately 0.1ml ) leaked out) and DEVICE CONNECTION ISSUE (Needle tip came loss from the syringe). On 16-Mar-2021, UNDERDOSE (Some of the vaccine (approximately 0.1ml ) leaked out) and DEVICE CONNECTION ISSUE (Needle tip came loss from the syringe) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided. Treatment details were not provided  It was reported that the Patient received more than Half of the vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jun-2021: Follow-up information received on 22-JUN-2021. Time of the 2nd dose administered was Updated and Fax number also updated.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Pain in extremity, Pruritus, Vaccination site swelling
Clinical narrative: itching on her left arm (wrist and hand); headache; sore arm; swelling at the injection site; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE SWELLING (swelling at the injection site), PRURITUS (itching on her left arm (wrist and hand)) and HEADACHE (headache) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm) and VACCINATION SITE SWELLING (swelling at the injection site). On 13-Mar-2021, the patient experienced PRURITUS (itching on her left arm (wrist and hand)) and HEADACHE (headache). The patient was treated with IBUPROFEN at a dose of 1 dosage form. On 13-Mar-2021, PAIN IN EXTREMITY (sore arm) and VACCINATION SITE SWELLING (swelling at the injection site) had resolved. On 14-Mar-2021, PRURITUS (itching on her left arm (wrist and hand)) and HEADACHE (headache) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter.   This case was linked to MOD-2021-042820 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 07-May-2021: Follow up received on 07-MAY-2021 and contains  details of second dose AE and informed that both 1st and 2nd dose AEs are now resolved. Declined further follow up.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). At the time of the report, PAIN IN EXTREMITY (sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 88.0
Sex: M
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: Nausea; Vomitting; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of NAUSEA (Nausea) and VOMITING (Vomitting) in an 88-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 010M20A and 012120) for COVID-19 vaccination.     No Medical History information was reported.   On 04-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Mar-2021, the patient experienced NAUSEA (Nausea) and VOMITING (Vomitting). At the time of the report, NAUSEA (Nausea) and VOMITING (Vomitting) outcome was unknown.            Concomitant medications were not provided.  Treatment information was not provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles outbreak; This spontaneous case was reported by an other health care professional and describes the occurrence of HERPES ZOSTER (shingles outbreak) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 031M20A) for COVID-19 vaccination.     No medical history was reported.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced HERPES ZOSTER (shingles outbreak). On 09-Mar-2021, HERPES ZOSTER (shingles outbreak) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the events was not applicable. No Concomitant  information was  provided. Patient took some antiviral medication to help with shingles outbreak. It resolved on 09-Mar-2021 but she still has scabs from the outbreak.   This case was linked to MOD-2021-046619 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: got infected with COVID-19 and had a very bad time, it was very serious; This spontaneous case was reported by a physician and describes the occurrence of COVID-19 (got infected with COVID-19 and had a very bad time, it was very serious) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (got infected with COVID-19 and had a very bad time, it was very serious). At the time of the report, COVID-19 (got infected with COVID-19 and had a very bad time, it was very serious) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.   Treatment information was not provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Product dose omission issue, Pruritus, Rhinorrhoea, SARS-CoV-2 antibody test
Clinical narrative: Runny Nose; Itchy Nose; Feeling Sick; Missed dose; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of RHINORRHOEA (Runny Nose), PRURITUS (Itchy Nose), MALAISE (Feeling Sick) and PRODUCT DOSE OMISSION ISSUE (Missed dose) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 043LV014) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure (High) and Allergy NOS. Concomitant products included METOPROLOL SUCCINATE, LOSARTAN, ATORVASTATIN, ESTRADIOL, SERTRALINE HCL, CLONAZEPAM, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) and CETIRIZINE for an unknown indication.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Missed dose). On 05-Mar-2021, the patient experienced RHINORRHOEA (Runny Nose), PRURITUS (Itchy Nose) and MALAISE (Feeling Sick). At the time of the report, RHINORRHOEA (Runny Nose), PRURITUS (Itchy Nose), MALAISE (Feeling Sick) and PRODUCT DOSE OMISSION ISSUE (Missed dose) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 10-Mar-2021, SARS-CoV-2 antibody test: negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Concomitant medications also included unspecified  glaucoma eye drops and nasal drops.  Treatment medication included corticosteroids for her allergy. Patient was on  antibiotic treatment
Sex: F
Vaccine: COVID19
Symptoms: Fatigue
Clinical narrative: exhausted; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (exhausted) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced FATIGUE (exhausted). At the time of the report, FATIGUE (exhausted) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  Treatment information in response to events was not provided.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dizziness, Feeding disorder, Feeling abnormal, Headache
Clinical narrative: Diarrhea; Couldn't see well; Couldn't eat anything.; Lay down for a while; Dry heaves; Dizziness; Fever; Headache; Vomiting; This spontaneous case was reported by a health care professional and describes the occurrence of DIARRHOEA (Diarrhea), VISUAL IMPAIRMENT (Couldn't see well), FEEDING DISORDER (Couldn't eat anything.), FEELING ABNORMAL (Lay down for a while) and RETCHING (Dry heaves) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), VISUAL IMPAIRMENT (Couldn't see well), FEEDING DISORDER (Couldn't eat anything.), FEELING ABNORMAL (Lay down for a while), RETCHING (Dry heaves), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomiting). On 16-Mar-2021, VISUAL IMPAIRMENT (Couldn't see well), FEEDING DISORDER (Couldn't eat anything.), FEELING ABNORMAL (Lay down for a while), RETCHING (Dry heaves), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomiting) had resolved. At the time of the report, DIARRHOEA (Diarrhea) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment information was specified.   This case was linked to MOD-2021-046614 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Retching, Visual impairment, Vomiting
Clinical narrative: Diarrhea; Couldn't see well; Couldn't eat anything.; Lay down for a while; Dry heaves; Dizziness; Fever; Headache; Vomiting; This spontaneous case was reported by a health care professional and describes the occurrence of DIARRHOEA (Diarrhea), VISUAL IMPAIRMENT (Couldn't see well), FEEDING DISORDER (Couldn't eat anything.), FEELING ABNORMAL (Lay down for a while) and RETCHING (Dry heaves) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 031M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced DIARRHOEA (Diarrhea), VISUAL IMPAIRMENT (Couldn't see well), FEEDING DISORDER (Couldn't eat anything.), FEELING ABNORMAL (Lay down for a while), RETCHING (Dry heaves), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomiting). On 16-Mar-2021, VISUAL IMPAIRMENT (Couldn't see well), FEEDING DISORDER (Couldn't eat anything.), FEELING ABNORMAL (Lay down for a while), RETCHING (Dry heaves), DIZZINESS (Dizziness), PYREXIA (Fever), HEADACHE (Headache) and VOMITING (Vomiting) had resolved. At the time of the report, DIARRHOEA (Diarrhea) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  No treatment information was specified.   This case was linked to MOD-2021-046614 (Patient Link).
Sex: M
Vaccine: COVID19
Symptoms: Pain, Vaccination site pruritus
Clinical narrative: SORENESS; FEELS LIKE AN ITCH; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (SORENESS) and VACCINATION SITE PRURITUS (FEELS LIKE AN ITCH) in a 77-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced PAIN (SORENESS) and VACCINATION SITE PRURITUS (FEELS LIKE AN ITCH). At the time of the report, PAIN (SORENESS) and VACCINATION SITE PRURITUS (FEELS LIKE AN ITCH) outcome was unknown.            No relevant concomitant medications were reported. No treatment information was provided.  Action taken with mRNA-1273 in response to the events were not applicable.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations
Clinical narrative: Heart race; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (Heart race) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Mar-2021, the patient experienced PALPITATIONS (Heart race). At the time of the report, PALPITATIONS (Heart race) had resolved. Unknown      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided.   This case was linked to MOD-2021-046413 (Patient Link).   Reporter did not allow further contact
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot
Clinical narrative: Red face; feeling hot on her body; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red face) and FEELING HOT (feeling hot on her body) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced ERYTHEMA (Red face) and FEELING HOT (feeling hot on her body). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, ERYTHEMA (Red face) and FEELING HOT (feeling hot on her body) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.    This case was linked to MOD21-055557, INC.-MOD-2021-046664 (E2B Linked Report).; Sender's Comments:  MOD21-055557:Crosslinked husband case, INC.-MOD-2021-046664:Crosslinked husband case
Sex: F
Vaccine: COVID19
Symptoms: Eating disorder, Illness, Influenza like illness, Sleep disorder
Clinical narrative: Flu-like symptoms; sick whole weekend; awake in and out of it; didnt eat or drink anything; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu-like symptoms), ILLNESS (sick whole weekend), SLEEP DISORDER (awake in and out of it) and EATING DISORDER (didnt eat or drink anything) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to at an unspecified dose. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 13-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu-like symptoms), ILLNESS (sick whole weekend), SLEEP DISORDER (awake in and out of it) and EATING DISORDER (didnt eat or drink anything). At the time of the report, INFLUENZA LIKE ILLNESS (Flu-like symptoms), ILLNESS (sick whole weekend), SLEEP DISORDER (awake in and out of it) and EATING DISORDER (didnt eat or drink anything) outcome was unknown.            Action taken with mRNA-1273 in response to the events was not Applicable.  no concomitant medications were provided.  no treatment medications were  provided.
Age: 16.0
Sex: F
Vaccine: COVID19
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: Pediatric patient received Moderna vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric patient received Moderna vaccine) in a 16-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 11-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric patient received Moderna vaccine). On 11-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Pediatric patient received Moderna vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant information was reported. Treatment information was not provided.
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Cold sweat, Fatigue, Hyperhidrosis, Influenza like illness, Myalgia
Clinical narrative: flu like symptoms; sweaty; clammy; bodyache; fatigue; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), MYALGIA (bodyache) and FATIGUE (fatigue) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL, ATENOLOL and CITALOPRAM HYDROCHLORIDE (ELOPRAM [CITALOPRAM HYDROCHLORIDE]) for an unknown indication.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 10-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), MYALGIA (bodyache), FATIGUE (fatigue) and VOMITING (vomiting). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), MYALGIA (bodyache) and FATIGUE (fatigue) outcome was unknown.            No treatment information was provided
Age: 91.0
Sex: M
Vaccine: COVID19
Symptoms: Vomiting
Clinical narrative: flu like symptoms; sweaty; clammy; bodyache; fatigue; vomiting; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), MYALGIA (bodyache) and FATIGUE (fatigue) in a 91-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LISINOPRIL, ATENOLOL and CITALOPRAM HYDROCHLORIDE (ELOPRAM [CITALOPRAM HYDROCHLORIDE]) for an unknown indication.   On 10-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 10-Mar-2021, the patient experienced INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), MYALGIA (bodyache), FATIGUE (fatigue) and VOMITING (vomiting). At the time of the report, INFLUENZA LIKE ILLNESS (flu like symptoms), HYPERHIDROSIS (sweaty), COLD SWEAT (clammy), MYALGIA (bodyache) and FATIGUE (fatigue) outcome was unknown.            No treatment information was provided
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Urticaria
Clinical narrative: large hives on the lower part of her right arm; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (large hives on the lower part of her right arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced URTICARIA (large hives on the lower part of her right arm). On 16-Mar-2021, URTICARIA (large hives on the lower part of her right arm) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient did not take anything to alleviate the symptoms. No concomitant information was reporte
Sex: M
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of pain in extremity (he could not sleep because of the pain in his left arm) and vaccination site pain (injection site pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 003A21A) for COVID-19 immunization. No medical history reported. On Mar 15, 2021, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Mar 15, 2021, patient experienced pain in extremity (he could not sleep because of the pain in his left arm) and vaccination site pain (injection site pain). At the time of the report, pain in extremity (he could not sleep because of the pain in his left arm) and vaccination site pain (injection site pain) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Acne, Cheilitis, Lip swelling
Clinical narrative: the reporter said patient had it's lips swollen; feeling like a pimple on the lips; upper lip super inflamed; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (the reporter said patient had it's lips swollen), ACNE (feeling like a pimple on the lips) and CHEILITIS (upper lip super inflamed) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     The patient's past medical history included Lip cosmetic procedure (lip fillers).    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LIP SWELLING (the reporter said patient had it's lips swollen), ACNE (feeling like a pimple on the lips) and CHEILITIS (upper lip super inflamed). The patient was treated with LISINOPRIL at a dose of 1 dosage form. At the time of the report, LIP SWELLING (the reporter said patient had it's lips swollen), ACNE (feeling like a pimple on the lips) and CHEILITIS (upper lip super inflamed) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were included. Patient reported that symptoms appeared 30 hours after vaccination. Patient went to a hospital to urgencies for 5 hours and they could lower the swollen lip.
Age: 90.0
Sex: F
Vaccine: COVID19
Symptoms: Burning sensation, Insomnia, Pain, Pain in extremity
Clinical narrative: a little sore arm/both legs were in pain; burning; terrible pain/ excruciating pain; couldn't sleep all night long; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (a little sore arm/both legs were in pain), BURNING SENSATION (burning), PAIN (terrible pain/ excruciating pain) and INSOMNIA (couldn't sleep all night long) in a 90-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concomitant products included PREGABALIN (LYRICA) for an unknown indication.   On 13-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Mar-2021, the patient experienced PAIN IN EXTREMITY (a little sore arm/both legs were in pain), BURNING SENSATION (burning), PAIN (terrible pain/ excruciating pain) and INSOMNIA (couldn't sleep all night long). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. On 14-Mar-2021, PAIN IN EXTREMITY (a little sore arm/both legs were in pain), BURNING SENSATION (burning), PAIN (terrible pain/ excruciating pain) and INSOMNIA (couldn't sleep all night long) had resolved. Unknown          Most recent FOLLOW-UP information incorporated above includes: On 06-May-2021: Report Uploaded. Patient is doing fine and declined further follow up.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Dizziness, Fatigue, Myalgia
Clinical narrative: tremendous pain in the muscles of her back,f eet, ankles, and arms.; pain in muscle of feet; Joint pain in her legs (both sides)/ lot of pain in her joints; pain in muscle of arm; tired; dizzy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), BACK PAIN (tremendous pain in the muscles of her back,f eet, ankles, and arms.), PAIN IN EXTREMITY (pain in muscle of feet), FATIGUE (tired) and ARTHRALGIA (Joint pain in her legs (both sides)/ lot of pain in her joints) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DIZZINESS (dizzy) and FATIGUE (tired). On 16-Mar-2021, the patient experienced BACK PAIN (tremendous pain in the muscles of her back,f eet, ankles, and arms.), PAIN IN EXTREMITY (pain in muscle of feet), ARTHRALGIA (Joint pain in her legs (both sides)/ lot of pain in her joints) and MYALGIA (pain in muscle of arm). At the time of the report, DIZZINESS (dizzy), BACK PAIN (tremendous pain in the muscles of her back,f eet, ankles, and arms.), PAIN IN EXTREMITY (pain in muscle of feet), FATIGUE (tired), ARTHRALGIA (Joint pain in her legs (both sides)/ lot of pain in her joints) and MYALGIA (pain in muscle of arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: tremendous pain in the muscles of her back,f eet, ankles, and arms.; pain in muscle of feet; Joint pain in her legs (both sides)/ lot of pain in her joints; pain in muscle of arm; tired; dizzy; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 16-Mar-2021 and was forwarded to Moderna on 16-Mar-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizzy), BACK PAIN (tremendous pain in the muscles of her back,f eet, ankles, and arms.), PAIN IN EXTREMITY (pain in muscle of feet), FATIGUE (tired) and ARTHRALGIA (Joint pain in her legs (both sides)/ lot of pain in her joints) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Rheumatoid arthritis.    On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Mar-2021, the patient experienced DIZZINESS (dizzy) and FATIGUE (tired). On 16-Mar-2021, the patient experienced BACK PAIN (tremendous pain in the muscles of her back,f eet, ankles, and arms.), PAIN IN EXTREMITY (pain in muscle of feet), ARTHRALGIA (Joint pain in her legs (both sides)/ lot of pain in her joints) and MYALGIA (pain in muscle of arm). At the time of the report, DIZZINESS (dizzy), BACK PAIN (tremendous pain in the muscles of her back,f eet, ankles, and arms.), PAIN IN EXTREMITY (pain in muscle of feet), FATIGUE (tired), ARTHRALGIA (Joint pain in her legs (both sides)/ lot of pain in her joints) and MYALGIA (pain in muscle of arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Rash
Clinical narrative: Her back, neck and shoulders have this rash/inner part of her arm has also this rash; Crusty feeling; This spontaneous case was reported by a consumer and describes the occurrence of RASH (Her back, neck and shoulders have this rash/inner part of her arm has also this rash) and FEELING ABNORMAL (Crusty feeling) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Feb-2021, the patient experienced RASH (Her back, neck and shoulders have this rash/inner part of her arm has also this rash) and FEELING ABNORMAL (Crusty feeling). At the time of the report, RASH (Her back, neck and shoulders have this rash/inner part of her arm has also this rash) and FEELING ABNORMAL (Crusty feeling) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.